NCT02536183 2023-08-29A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid TumorsChildren's National Research InstitutePhase 1 Terminated2 enrolled
NCT00003926 2017-11-29Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid TumorsMasonic Cancer Center, University of MinnesotaPhase 1 Terminated13 enrolled